Volume 13, Number 12—December 2007
Research
Susceptibility of Canada Geese (Branta canadensis) to Highly Pathogenic Avian Influenza Virus (H5N1)
Table 1
Animal ID | 0 dpi cELISA (NP % inhibition) | 0 dpi H5 HI assay† | 14 dpi (H5N2) cELISA (NP % inhibition) | 21 dpi (H5N2) H5 HI assay† | 20–21 dpi (H5N1) cELISA (NP) | 20–21 dpi (H5N1) H5 HI assay† |
---|---|---|---|---|---|---|
Juveniles | ||||||
852S/27R | Neg (20) | <8 | Pos (66) | 16 | Euthanized or died‡ | |
853S/28R | Neg (13) | <8 | Pos (64) | 64 | Pos (46% inhibition) | 8 |
856S/31R | Neg (21) | <8 | Pos (57) | 256 | Euthanized | |
858S/33R | Neg (22) | <8 | Pos (55) | 128 | Pos (48% inhibition) | 64 |
859S/34R | Neg (19) | <8 | Pos (49) | 256 | Euthanized | |
851S/26R | Neg (24) | <8 | Euthanized | |||
854S/29R | Neg (23) | <8 | Euthanized | |||
855S/30R | Neg (22) | <8 | Euthanized | |||
860S/35R | Neg (24) | <8 | Euthanized | |||
861S/36R | Neg (20) | <8 | ||||
857S/32Y | Neg (18) | <8 | ||||
Adults | ||||||
842S/42Y | Pos (93) | <8 | Pos (99) | 512 | Euthanized | |
844S/44Y | Neg (23) | <8 | Pos (99) | 64 | Pos (46% inhibition) | <8 |
845S/45Y | Pos (58) | <8 | Pos (96) | 8 | Euthanized | |
846S/46Y | Pos (76) | <8 | Pos (96) | <8 | Pos (63% inhibition) | <8 |
847S/47Y | Pos (74) | <8 | Pos (99) | ND | Euthanized | |
840S/40Y | Pos (45) | <8 | Pos (99% inhibition) | >4,096 | ||
841S/41Y | Neg (22) | <8 | Euthanized | |||
843S/43Y | Pos (78) | <8 | Euthanized | |||
848S/48Y | Pos (39) | <8 | Pos (98% inhibition) | 64 | ||
849S/49Y | Pos (93) | <8 | Pos (98% inhibition) | 32 | ||
850S/50Y | Pos (85) | <8 |
*NP, nucleoprotein; cELISA, competitive ELISA; dpi, days postinfection; Neg, negative (<30% inhibition); Pos, positive (≥30% inhibition); HI, hemagglutinin inhibition; ND, not determined.
†4 hemagglutinin units of A/duck/British Columbia/26–6/2005 (H5N2) used in assay.
‡Euthanized or died before day 20–21 postinoculation with virus (H5N1).
Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.